Assessment of a HER2 scoring system for colorectal cancer: results from a validation studyEmanuele Valtorta, Marcello Gambacorta, Massimo Rugge et al.|Modern Pathology|2015Cited by 317
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancersSandra Misale, Alberto Bardelli, Ivana Božić et al.|Nature Communications|2015Cited by 128
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective studyGrazia Arpino, Sabino De Placido, Andrea Michelotti et al.|Journal of Cancer Research and Clinical Oncology|2015Cited by 15